PMID- 22000441 OWN - NLM STAT- MEDLINE DCOM- 20111209 LR - 20191210 IS - 1008-8830 (Print) IS - 1008-8830 (Linking) VI - 13 IP - 10 DP - 2011 Oct TI - [Effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of C/EBPalpha and PPARgamma]. PG - 823-6 AB - OBJECTIVE: This study examined the effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of CCAAT enhancer binding protein alpha (C/EBPalpha) and peroxisome proliferation activated receptor gamma (PPARgamma), in order to study the possible roles of insulin receptor substrate (IRSs)/PI3K signal pathway in the differentiation of preadipocytes. METHODS: The mouse 3T3-L1 cells were cultured normally and divided into experimental and control groups. 3T3-L1 cells in the experimental group were treated with PI3K inhibitor LY294002 (25 mumol/L) and those in the control group were treated with DMSO culture medium. 3-isobutyl-1-methylxanthine (IBMX) (0.5 mmol/L), dexamethasone (10-6 mol/L) and insulin (5 mug/mL) were used to induce the differentiation of 3T3-L1 preadipocytes in both groups. Before culture, and 2, 4 and 8 days after culture, the cells were collected to detect the expression of C/EBPalpha and PPARgamma by real-time PCR and Western blot assays. The lipid droplets of 3T3-L1 preadipocytes were observed by oil-red O staining. RESULTS: PI3K inhibitor LY294002 did not affect the expression of C/EBPalpha and PPARgamma in un-induced 3T3-L1 preadipocytes (P>0.05), but decreased the expression of C/EBPalpha and PPARgamma during the in vitro induced differentiation of 3T3-L1 preadipocytes compared with the control group (P<0.05 or 0.01). The lipid droplets count was greatly reduced by LY294002. CONCLUSIONS: PI3K inhibitor LY294002 can inhibit the differentiation of mouse 3T3-LI preadipocytes and the expression of C/EBPalpha and PPARgamma in the differentiation of 3T3-LI preadipoeytes, suggesting that IRSs/PI3K signal pathway may play an important role in the differentiation of 3T3-L1 preadipocytes by regulating the expression of C/EBPalpha and PPARgamma. FAU - Gao, Jin-Zhi AU - Gao JZ AD - Department of Pediatrics, Huazhong University of Science and Technology, Wuhan, China. FAU - Zheng, Rui-Dan AU - Zheng RD FAU - Wang, Cheng-Bin AU - Wang CB FAU - Ying, Yan-Qin AU - Ying YQ FAU - Luo, Xiao-Ping AU - Luo XP LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhongguo Dang Dai Er Ke Za Zhi JT - Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics JID - 100909956 RN - 0 (CCAAT-Enhancer-Binding Protein-alpha) RN - 0 (Chromones) RN - 0 (Morpholines) RN - 0 (PPAR gamma) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (RNA, Messenger) RN - 31M2U1DVID (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) SB - IM MH - 3T3-L1 Cells MH - Adipocytes/cytology/*drug effects MH - Animals MH - CCAAT-Enhancer-Binding Protein-alpha/analysis/*genetics MH - Cell Differentiation/drug effects MH - Chromones/*pharmacology MH - Gene Expression Regulation/drug effects MH - Mice MH - Morpholines/*pharmacology MH - PPAR gamma/analysis/*genetics MH - *Phosphoinositide-3 Kinase Inhibitors MH - RNA, Messenger/analysis EDAT- 2011/10/18 06:00 MHDA- 2011/12/14 06:00 CRDT- 2011/10/18 06:00 PHST- 2011/10/18 06:00 [entrez] PHST- 2011/10/18 06:00 [pubmed] PHST- 2011/12/14 06:00 [medline] AID - 1008-8830(2011)10-0823-04 [pii] PST - ppublish SO - Zhongguo Dang Dai Er Ke Za Zhi. 2011 Oct;13(10):823-6.